FineMark National Bank & Trust’s Boston Scientific BSX Stock Holding History

FineMark National Bank & Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$219K	Sell	2,299 -27	-1%	-$2.65K	0.01%	418
2025 Q3	$227K	Sell	2,326 -1	-0%	-$104	0.01%	413
2025 Q2	$250K	Buy	2,327 +26	+1%	+$2.63K	0.01%	400
2025 Q1	$232K	Hold	2,301	–	–	0.01%	392
2024 Q4	$206K	Buy	+2,301	New	+$203K	0.01%	410
2017 Q1	–	Sell	-90	Closed	-$2K	–	450
2016 Q4	$2K	Hold	90	–	–	﹤0.01%	1152
2016 Q3	$2K	Hold	90	–	–	﹤0.01%	1158
2016 Q2	$2K	Hold	90	–	–	﹤0.01%	1187
2016 Q1	$2K	Hold	90	–	–	﹤0.01%	1122
2015 Q4	$2K	Hold	90	–	–	﹤0.01%	1152
2015 Q3	$1K	Hold	90	–	–	﹤0.01%	1355
2015 Q2	$2K	Hold	90	–	–	﹤0.01%	1234
2015 Q1	$2K	Hold	90	–	–	﹤0.01%	1235
2014 Q4	$1K	Hold	90	–	–	﹤0.01%	1322
2014 Q3	$1K	Hold	90	–	–	﹤0.01%	1304
2014 Q2	$1K	Hold	90	–	–	﹤0.01%	1323
2014 Q1	$1K	Hold	90	–	–	﹤0.01%	1341
2013 Q4	$1K	Buy	+90	New	+$1.06K	﹤0.01%	1407

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

FineMark National Bank & Trust's BSX Position: Q4 2025 in Review

FineMark National Bank & Trust reduced its Boston Scientific (BSX) stake by 1.2% in Q4 2025, selling an estimated $2.65K and leaving 2,299 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #418.

FineMark National Bank & Trust first reported a position in BSX in Q4 2013 and has held it in 18 quarters since. The position peaked at $250K in Q2 2025. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

FineMark National Bank & Trust held 2,299 shares of Boston Scientific worth $219K as of Q4 2025.
FineMark National Bank & Trust sold 27 Boston Scientific shares in Q4 2025, an estimated $2.65K.
Boston Scientific made up 0.01% of FineMark National Bank & Trust's portfolio in Q4 2025, its #418 holding.
FineMark National Bank & Trust first reported a position in Boston Scientific in Q4 2013 and has held it in 18 quarters since.
FineMark National Bank & Trust's Boston Scientific position peaked at $250K in Q2 2025.
1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.